摘要
目的对宫颈癌三级筛查的临床结果进行研究分析,旨在提高对宫颈癌诊治措施。方法在2016年9月至2017年9月随机选择某地方198例妇女作为本次研究分析对象,对所有妇女进行巴氏细胞学以及宫颈刮片膜式液基薄层细胞学筛查,对出现宫颈癌患病情况进行研究分析。结果两种筛查方式中,巴氏细胞学筛查中阳性人数为8例,阳性率为4.04%,对宫颈炎、鳞癌以及宫颈上皮内瘤变的灵敏度分别为84.00%、83.00%、85.00%;宫颈刮片膜式液基薄层细胞学筛查中阳性人数为10例,阳性率为5.05%,对宫颈炎、鳞癌以及宫颈上皮内瘤变的灵敏度分别为94.00%、96.50%、95.00%。结论在对宫颈癌三级筛查中,膜式液基薄层细胞学的灵敏度以及筛检结果的准确度均明显高于巴氏细胞学筛查,在临床筛查中值得推广应用。
Objective To analyze the clinical results of cervical cancer screening in order to improve the diagnosis and treatment of cervical cancer.Methods From September 2016 to September 2017,198 women at a random place were selected as the subject of this study.Pap cytology and cervical smear-based liquid-based thin-layer cytology screening were performed on all women.The incidence of cervical cancer was analyzed.Results In the two screening methods,the number of positive patients in Pap cytology screening was 8,and the positive rate was 4.04%.The sensitivities to cervicitis,squamous cell carcinoma,and cervical intraepithelial neoplasia were 84.00% and 83.00%,respectively 85.00%;The positive rate of cervical smear film based liquid based cytology screening was 10,with a positive rate of 5.05%,and the sensitivity to cervicitis,squamous cell carcinoma,and cervical intraepithelial neoplasia was 94.00% and 96.50%,respectively 95.00%.Conclusion In the three-stage screening for cervical cancer,the sensitivity of the thin film-based liquid cytology and the accuracy of the screening results were significantly higher than those of Pap cytology screening,and it is worthy of popularization and application in clinical screening.
作者
麻彦霞
MA Yan-xia(The Traditional Chinese Medical Hospital of Pingxiang County,Xingtai,Hebei,05450)
出处
《智慧健康》
2018年第13期62-63,共2页
Smart Healthcare
关键词
宫颈癌筛查
巴氏细胞学
宫颈刮片膜式液基薄层细胞学
Cervical cancer screening
Pap cytology
Cervical smear film Liquid-based thin-layer cytology
